72,275 Shares in U.S. Physical Therapy, Inc. (NYSE:USPH) Acquired by Silvercrest Asset Management Group LLC

Silvercrest Asset Management Group LLC bought a new position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 72,275 shares of the company’s stock, valued at approximately $8,158,000. Silvercrest Asset Management Group LLC owned 0.48% of U.S. Physical Therapy as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently made changes to their positions in USPH. Vanguard Group Inc. increased its stake in shares of U.S. Physical Therapy by 1.7% during the third quarter. Vanguard Group Inc. now owns 1,036,203 shares of the company’s stock worth $95,051,000 after buying an additional 17,156 shares during the period. Raymond James & Associates increased its stake in shares of U.S. Physical Therapy by 28.4% during the fourth quarter. Raymond James & Associates now owns 15,699 shares of the company’s stock worth $1,462,000 after buying an additional 3,468 shares during the period. True North Advisors LLC increased its stake in shares of U.S. Physical Therapy by 4.6% during the fourth quarter. True North Advisors LLC now owns 6,019 shares of the company’s stock worth $561,000 after buying an additional 265 shares during the period. Trust Point Inc. purchased a new stake in shares of U.S. Physical Therapy during the fourth quarter worth approximately $470,000. Finally, Boston Trust Walden Corp increased its stake in shares of U.S. Physical Therapy by 0.7% during the fourth quarter. Boston Trust Walden Corp now owns 546,958 shares of the company’s stock worth $50,944,000 after buying an additional 3,616 shares during the period.

U.S. Physical Therapy Stock Performance

Shares of U.S. Physical Therapy stock opened at $98.17 on Wednesday. The firm has a market capitalization of $1.48 billion, a P/E ratio of 79.81, a P/E/G ratio of 3.77 and a beta of 1.38. U.S. Physical Therapy, Inc. has a 52 week low of $78.08 and a 52 week high of $120.65. The company has a quick ratio of 2.16, a current ratio of 2.16 and a debt-to-equity ratio of 0.28. The firm’s 50 day moving average is $96.09 and its two-hundred day moving average is $100.08.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings results on Tuesday, May 7th. The company reported $0.51 EPS for the quarter, missing the consensus estimate of $0.58 by ($0.07). The company had revenue of $155.70 million during the quarter, compared to analysts’ expectations of $153.30 million. U.S. Physical Therapy had a net margin of 4.72% and a return on equity of 8.03%. The business’s revenue for the quarter was up 4.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.59 earnings per share. Research analysts forecast that U.S. Physical Therapy, Inc. will post 2.84 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, June 14th. Stockholders of record on Thursday, May 23rd were given a dividend of $0.44 per share. The ex-dividend date of this dividend was Wednesday, May 22nd. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.79%. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 143.09%.

Insider Transactions at U.S. Physical Therapy

In other news, CEO Christopher J. Reading sold 2,900 shares of the firm’s stock in a transaction that occurred on Thursday, May 30th. The shares were sold at an average price of $100.26, for a total transaction of $290,754.00. Following the transaction, the chief executive officer now directly owns 95,838 shares in the company, valued at $9,608,717.88. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, CEO Christopher J. Reading sold 2,900 shares of the firm’s stock in a transaction that occurred on Thursday, May 30th. The shares were sold at an average price of $100.26, for a total transaction of $290,754.00. Following the transaction, the chief executive officer now directly owns 95,838 shares in the company, valued at $9,608,717.88. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, COO Graham D. Reeve sold 1,724 shares of the firm’s stock in a transaction that occurred on Friday, May 10th. The stock was sold at an average price of $105.46, for a total transaction of $181,813.04. Following the transaction, the chief operating officer now owns 6,970 shares in the company, valued at $735,056.20. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 10,724 shares of company stock worth $1,114,385. Insiders own 1.70% of the company’s stock.

Analyst Ratings Changes

Separately, Barrington Research reiterated an “outperform” rating and issued a $122.00 price target on shares of U.S. Physical Therapy in a research note on Thursday, May 9th. One investment analyst has rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $119.50.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.